Wikidata entity: Q5186964
C₂₁H₂₂Cl₂FN₅O (P274)
Quantities
| P2067 | mass | 449.119 |
| P3780 | active ingredient in | ... | Q29006680 (Xalkori) | Xalkori |
| P233 | canonical SMILES | String | CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N | ??? |
| P373 | Commons category | String | Crizotinib | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N | ??? |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q55998694 (neuroblastoma, susceptibility to) | neuroblastoma, susceptibility to |
| P2175 | medical condition treated | ... | Q3658562 (non-small-cell lung carcinoma) | non-small-cell lung carcinoma |
| P2175 | medical condition treated | ... | Q6030100 (inflammatory myofibroblastic tumour) | inflammatory myofibroblastic tumour |
| P2175 | medical condition treated | ... | Q18556109 (bronchus carcinoma) | bronchus carcinoma |
| P129 | physically interacts with | ... | Q5005897 (MET proto-oncogene, receptor tyrosine kinase) | MET proto-oncogene, receptor tyrosine kinase |
| P129 | physically interacts with | ... | Q21111336 (ALK receptor tyrosine kinase) | ALK receptor tyrosine kinase |
| P3489 | pregnancy category | ... | Q3679274 (Australian pregnancy category D) | Australian pregnancy category D |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q118551 (clarithromycin) | clarithromycin |
| P769 | significant drug interaction | ... | Q144085 (pimozide) | pimozide |
| P769 | significant drug interaction | ... | Q174259 (droperidol) | droperidol |
| P769 | significant drug interaction | ... | Q189522 (quinine) | quinine |
| P769 | significant drug interaction | ... | Q176533 (alfentanil) | alfentanil |
| P769 | significant drug interaction | ... | Q179996 ((RS)-methadone) | (RS)-methadone |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411229 (itraconazole) | itraconazole |
| P769 | significant drug interaction | ... | Q213511 (erythromycin) | erythromycin |
| P769 | significant drug interaction | ... | Q228143 (zuclopenthixol) | zuclopenthixol |
| P769 | significant drug interaction | ... | Q251347 (haloperidol) | haloperidol |
| P769 | significant drug interaction | ... | Q7739 (arsenic trioxide) | arsenic trioxide |
| P769 | significant drug interaction | ... | Q407883 (ketoconazole) | ketoconazole |
| P769 | significant drug interaction | ... | Q407972 (chlorpromazine) | chlorpromazine |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P769 | significant drug interaction | ... | Q421136 (sorafenib) | sorafenib |
| P769 | significant drug interaction | ... | Q421937 ((RS)-hydroxyzine) | (RS)-hydroxyzine |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q411325 (atenolol) | atenolol |
| P769 | significant drug interaction | ... | Q411648 (tacrolimus) | tacrolimus |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408535 (quetiapine) | quetiapine |
| P769 | significant drug interaction | ... | Q422618 (ritonavir) | ritonavir |
| P769 | significant drug interaction | ... | Q423364 (propranolol) | propranolol |
| P769 | significant drug interaction | ... | Q423762 (paclitaxel) | paclitaxel |
| P769 | significant drug interaction | ... | Q424238 (domperidone) | domperidone |
| P769 | significant drug interaction | ... | Q424940 (moxifloxacin) | moxifloxacin |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q412236 (voriconazole) | voriconazole |
| P769 | significant drug interaction | ... | Q412327 (nilotinib) | nilotinib |
| P769 | significant drug interaction | ... | Q419186 (ergotamine) | ergotamine |
| P769 | significant drug interaction | ... | Q420323 (lapatinib) | lapatinib |
| P769 | significant drug interaction | ... | Q420586 (celiprolol) | celiprolol |
| P769 | significant drug interaction | ... | Q412515 (bisoprolol) | bisoprolol |
| P769 | significant drug interaction | ... | Q412534 (carvedilol) | carvedilol |
| P769 | significant drug interaction | ... | Q424952 (nadolol) | nadolol |
| P769 | significant drug interaction | ... | Q425120 (disopyramide) | disopyramide |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q3896970 (pasireotide) | pasireotide |
| P769 | significant drug interaction | ... | Q3993743 ((Z)-Toremifene) | (Z)-Toremifene |
| P769 | significant drug interaction | ... | Q5473363 (fosphenytoin) | fosphenytoin |
| P769 | significant drug interaction | ... | Q5908266 (idelalisib) | idelalisib |
| P769 | significant drug interaction | ... | Q5984881 (ibrutinib) | ibrutinib |
| P769 | significant drug interaction | ... | Q408556 (levobunolol) | levobunolol |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q409468 ((RS)-metoprolol) | (RS)-metoprolol |
| P769 | significant drug interaction | ... | Q27139135 (dasatinib monohydrate) | dasatinib monohydrate |
| P769 | significant drug interaction | ... | Q425729 (ivabradine) | ivabradine |
| P769 | significant drug interaction | ... | Q736270 (mefloquine) | mefloquine |
| P769 | significant drug interaction | ... | Q794162 (betaxolol) | betaxolol |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410011 (ondansetron) | ondansetron |
| P769 | significant drug interaction | ... | Q894611 (bosutinib) | bosutinib |
| P769 | significant drug interaction | ... | Q958087 (labetalol) | labetalol |
| P769 | significant drug interaction | ... | Q3011604 (dabrafenib) | dabrafenib |
| P769 | significant drug interaction | ... | Q412690 (galantamine) | galantamine |
| P769 | significant drug interaction | ... | Q413591 (sotalol) | sotalol |
| P769 | significant drug interaction | ... | Q415081 (donepezil) | donepezil |
| P769 | significant drug interaction | ... | Q7157043 (pazopanib) | pazopanib |
| P769 | significant drug interaction | ... | Q7914515 (vandetanib) | vandetanib |
| P769 | significant drug interaction | ... | Q21011233 (ceritinib) | ceritinib |
| P769 | significant drug interaction | ... | Q416206 (pentamidine) | pentamidine |
| P769 | significant drug interaction | ... | Q417542 (sunitinib) | sunitinib |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q418101 (pindolol) | pindolol |
| P769 | significant drug interaction | ... | Q418130 (nebivolol) | nebivolol |
| P769 | significant drug interaction | ... | Q418139 (esmolol) | esmolol |
| P769 | significant drug interaction | ... | Q418857 (acebutolol) | acebutolol |
| P3364 | stereoisomer of | ... | Q27467066 (3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine) | 3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine |
| P279 | subclass of | ... | Q82296813 (critozinib (unspec. stereochem.)) | critozinib (unspec. stereochem.) |
| P2868 | subject has role | ... | Q50348938 (xenobiotic-transporting ATPase inhibitor) | xenobiotic-transporting ATPase inhibitor |
| P2868 | subject has role | ... | Q7251487 (protein kinase inhibitors) | protein kinase inhibitors |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | crizotinib | ??? |
Why not click here or view trends?
log id: 1626497